P/E của cổ phiếu GSK là bao nhiêu?

GLAXOSMITHKLINE PLC ADR (GSK) hiện giao dịch ở mức P/E 21.64 lần.

ROE của cổ phiếu GSK là bao nhiêu?

GLAXOSMITHKLINE PLC ADR có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 27.32%.

Tỷ suất cổ tức của GSK là bao nhiêu?

GLAXOSMITHKLINE PLC ADR có tỷ suất cổ tức 3.41%.

Điểm chất lượng (Quality Score) của GSK là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của GSK ở mức 62/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu GSK không?

Điểm AI Timing của GSK là 50/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu GSK thuộc ngành nào?

GLAXOSMITHKLINE PLC ADR được xếp vào ngành Healthcare >> Drug Manufacturers - General trên sàn NYSE

Cổ phiếu GSK (NYSE) | GLAXOSMITHKLINE PLC ADR

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

GSK AI Analysis Summary

Our AI summary for GSK: GLAXOSMITHKLINE PLC ADR (NYSE), Healthcare >> Drug Manufacturers - General sector. The stock currently trades at a P/E of 21.64, ROE of 27.32%, a dividend yield of 3.41%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 50/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

GSK

GLAXOSMITHKLINE PLC ADR

US:NYSE STOCK Healthcare >> Drug Manufacturers - General

USD 51.69

-0.38 (-0.73%) Day Change

Watchlist Portfolio Compare Chart

21.64

P/E

2.53

D/E

27.3%

ROE

7.8%

ROA

3.41%

Div Yield

0.28

PEG

GLAXOSMITHKLINE PLC ADR
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 51.69 Price -0.38 (-0.73%) Day Change	NEWS SCORE: N/A

GSK Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: [-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Tốt , ...

Yếu tố Chất lượng

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	1023
Magic Formula Rank by ROE	1023
Magic Formula Rank by ROIC	1217
Price	51.69
PBV / Sector	6.07 / 2.68
Earning Per Share	2.39

PE / Sector	21.64 / 27.65
PEG or PE/Growth / Sector	0.28 / 0.28 GREAT
Average 1M Daily Value	229.78 M GREAT
Average 1W Daily Value	301.10 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

70%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	14.52 / 17.30
NPM Average (%) / Sector	21.50 / 17.60 GREAT
NPM Change Average (%) / Sector	-5.36 / 92.67
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	7.81 / 8.73
ROA Average (%) / Sector	10.59 / 8.56
ROA Change Average (%) / Sector	-1.96 / 94.23
ROE (%) / Sector	27.32 / 26.78 GOOD
ROE Average (%) / Sector	50.24 / 13.05 GREAT
ROE Change Average (%) / Sector	-12.67 / 96.64
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

54%

Dividend (%) / Sector	3.41 / 2.40 GOOD
Dividend Average (%) / Sector	4.25 / 3.39 GOOD
Dividend Change Average (%) / Sector	-9.08 / 4.92

Chi tiết đăng ký

Analyze Date	2026-08-01 07:59:56
Symbol	GSK
Name	GLAXOSMITHKLINE PLC ADR
Sector	Healthcare >> Drug Manufacturers - General
Market	NYSE
Listed Shares	2,003.45 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	104,319.44 / 256,404.20

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 79 New Oxford Street, London, United Kingdom, WC1A 1DG

Phone: 44 20 8047 5000

Website: https://www.gsk.com

Employees: 66,841

Sector: Healthcare >> Drug Manufacturers - General

Description: GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.